ANAGENEX
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
ANAGENEX
Industry:
Biotechnology Information Technology Life Science
Founded:
2020-01-01
Website Url:
http://www.anagenex.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
37.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Google Apps For Business Typekit Squarespace
Similar Organizations
ApexQubit
ApexQubit is a biotechnology company that is harnessing frontier technologies for discovery of new medicines and better health for humanity.
HealthLytix
HealthLytix is a healthcare technology company using genomics and medical imaging to revolutionize screening and early detection of disease
Heliase Genomics
Heliase Genomics is a synthetic biology company that surveys nature for commercially valuable products.
Current Advisors List
Current Employees Featured
Founder
Investors List
Menlo Ventures
Menlo Ventures investment in Series A - Anagenex
Air Street Capital
Air Street Capital investment in Series A - Anagenex
Obvious Ventures
Obvious Ventures investment in Series A - Anagenex
Lux Capital
Lux Capital investment in Series A - Anagenex
Catalio Capital Management
Catalio Capital Management investment in Series A - Anagenex
Khosla Ventures
Khosla Ventures investment in Series A - Anagenex
Menlo Ventures
Menlo Ventures investment in Seed Round - Anagenex
Obvious Ventures
Obvious Ventures investment in Seed Round - Anagenex
Air Street Capital
Air Street Capital investment in Seed Round - Anagenex
Khosla Ventures
Khosla Ventures investment in Seed Round - Anagenex
More informations about "Anagenex"
Anagenex - Crunchbase Company Profile & Funding
Anagenex uses AI to accelerate the drug discovery process by analyzing billions of compounds to find potential medicines. Custom Synthesized Compounds Testing Billions of custom โฆSee details»
About - Anagenex
Jun 8, 2022 Adrian Schreyer is a pioneering leader in AI powered drug discovery with extensive experience in drug development. Prior to joining Anagenex, he spent over a decade at โฆSee details»
Anagenex
Anagenex 20 Maguire Rd Suite 302 Lexington, MA 02421 (978) 444-2649 ...See details»
Anagenex 2025 Company Profile: Valuation, Funding & Investors
Feb 21, 2020 Anagenex General Information Description. Developer of drug discovery platform designed for radically accelerating small molecule drug discovery and finding pharmaceutical โฆSee details»
Anagenex - LinkedIn
Anagenex | 1,910 followers on LinkedIn. Evolving new small molecule medicines by combining ultra high throughput biochemistry and machine learning | Discovering new medicines by combining ultra ...See details»
ANAGENEX, INC. Company Profile | Lexington, MA | Competitors ...
Find company research, competitor information, contact details & financial data for ANAGENEX, INC. of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»
Anagenex - Contacts, Employees, Board Members, Advisors
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets. ... Experience the new Crunchbase, powered by AI . Experience โฆSee details»
Anagenex - Funding, Financials, Valuation & Investors - Crunchbase
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets. New. Resources. Advanced Search. ... How much funding has this โฆSee details»
Anagenex, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Anagenex, Inc. with its drug pipeline, therapeutic area, technology platform, 12 news, Disease Domain:Neoplasms, Technology Platform:Chemical drugs, Drug ...See details»
Anagenex, Inc. (Anagenex, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅ โฆ
Anagenexโs first programs addressing PRMT5 and MAT2A fit this validated human target hypothesis. PRMT5 is a pan-essential gene and MAT2A inhibition leads to inhibition of โฆSee details»
Anagenex - Overview, News & Similar companies | ZoomInfo.com
Mar 3, 2024 Who is Anagenex. Anagenex is a pre-clinical biotechnology innovator advancing drug discovery through its small molecule directed evolution platform. The company's u nique, โฆSee details»
Anagenex Company Profile - Office Locations, Competitors ... - Craft
Anagenex has 5 employees at their 1 location and $30 m in total funding,. See insights on Anagenex including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
Anagenex | Catalio Capital Management
Anagenex is building a novel drug discovery platform that utilizes large, iterative DNA-encoded drug libraries and machine learning to enable drug discovery against difficult targets. Their โฆSee details»
Anagenex Company Information - Funding, Investors, and More
Anagenex is a directed Evolution Platform for Small Molecule Discovery founded in 2019. Seedtable Score 76 Startups. 1. Funding Rounds. $30.0m. Money raised. About; Insights; โฆSee details»
Anagenex - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Founder Spotlight #27: Nicolas Tilmans @ Anagenex - Medium
Nov 2, 2021 Nicolas Tilmans is Founder & CEO @Anagenex, a company applying massively parallel biochemistry and machine learning to find new medicines. He has spent most of his โฆSee details»
Anagenex - GitHub
Cddd Public Forked from jrwnter/cddd. Implementation of the Paper "Learning Continuous and Data-Driven Molecular Descriptors by Translating Equivalent Chemical Representations" by โฆSee details»
Anagenex Company Profile: Overview and Full News Analysis
Anagenex is a Massachusetts-based company focused on AI-driven drug discovery to accelerate the process of finding medicines for various diseases. The traditional drug discovery timeline โฆSee details»
Anagenex - Updates, News, Events, Signals & Triggers - Crunchbase
Anagenex is engaged in developing a machine learning-driven platform for drug discovery, focusing on challenging targets. The platform involves a process of directed evolution of โฆSee details»
Home - Anagenix
The most powerful trend driving demand in the global nutraceutical and supplement market is consumersโ increasing desire for wholefood ingredients that are โnaturally functionalโ.See details»